Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
- PMID: 30715158
- DOI: 10.1093/brain/awz006
Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
Comment on
-
Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.Brain. 2019 Mar 1;142(3):e8. doi: 10.1093/brain/awz005. Brain. 2019. PMID: 30715143 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials